13 hours ago
7
A drug designed to shut down fat production inside the liver could become a major new weapon against one of the world's fastest-growing liver diseases.
Researchers at University of California San Diego School of Medicine reported that an experimental treatment called ION224 produced significant improvements in people with metabolic dysfunction-associated steatohepatitis (MASH), an aggressive form of fatty liver disease strongly linked to obesity and type 2 dia...
English (US) ·